| Fulvestrant investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 67show all (up to 200) |
|---|
| → investigated in trials for | Malignant Breast Neoplasmcancer_family 224 trials (76 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 224 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Neoplasmcancer_family 64 trials (25 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Neoplasm | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 25 trials (15 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Carcinoma 17 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Ovarian Neoplasm 12 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Ovarian Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Neoplasm 10 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hormone Receptor-Positive Breast Carcinoma 8 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Hormone Receptor-Positive Breast Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Non-Small Cell Carcinomasubtype 8 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HER2-Positive Breast Carcinomamolecular_subtype 7 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | HER2-Positive Breast Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HER2-Negative Breast Carcinoma 6 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | HER2-Negative Breast Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Invasive Breast Carcinoma 6 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Invasive Breast Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Endometrial Neoplasm 6 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Endometrial Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ovarian Carcinoma 6 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Ovarian Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adult Solid Neoplasm 5 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Adult Solid Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Prostate Neoplasm 5 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Prostate Neoplasm | 5 | Observed | clinicaltrials | graph → |